GlassScriptPhysician profile
Ammar Mahmoud
NPI 1235578485
$56,988.03
in general payments reported to CMS, 2019-2025
13 companies · $24K in 2025
The $24K reported for 2025 was more than what 97% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2021: $2,899 · 2022: $3,063 · 2023: $10K · 2024: $16K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $15K · Consulting Fee: $9,375 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $9,300 · Food and Beverage: $8,377 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,775.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,447.93 |
| Consulting Fee | $9,375.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $9,300.00 |
| Food and Beverage | $8,376.65 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,775.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $32,170.46 | 2019-2025 | Proclaim, Durata, Eterna |
| Boston Scientific Corporation | $15,484.03 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Medtronic, INC. | $4,410.32 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Biotronik Nro, INC. | $2,276.16 | 2024 | Prospera |
| Bioventus LLC | $763.11 | 2023-2025 | Stimrouter Implantable Kit, Stimrouter Implantable Kit |
| Spr Therapeutics, INC | $589.41 | 2023-2025 | Sprint Pns System |
| Saluda Medical Americas, INC. | $315.37 | 2024-2025 | Evoke |
| Si-Bone, INC. | $293.20 | 2025 | |
| Painteq LLC | $276.90 | 2021-2025 | Painteq |
| Medtronic USA, INC. | $187.48 | 2019 | |
| Vertos Medical, INC. | $152.23 | 2021-2023 | Mild Device Kit |
| Nalu Medical, INC. | $45.55 | 2025 | Nalu Neurostimulation System |
| Masimo Corporation | $23.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Mahmoud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.